These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8732757)
1. The structural homology between uteroglobin and the pore-forming domain of colicin A suggests a possible mechanism of action for uteroglobin. de la Cruz X; Lee B Protein Sci; 1996 May; 5(5):857-61. PubMed ID: 8732757 [TBL] [Abstract][Full Text] [Related]
2. Interaction of synthetic peptides from annexin I and uteroglobin with lipid monolayers and their effect on phospholipase A2 activity. Newman RH; Freemont PS; Barton GJ; Crumpton MJ Biochem Soc Trans; 1990 Dec; 18(6):1233-4. PubMed ID: 2150950 [No Abstract] [Full Text] [Related]
3. Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides. Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB Adv Exp Med Biol; 1990; 279():137-60. PubMed ID: 2151414 [No Abstract] [Full Text] [Related]
4. Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action. Facchiano A; Cordella-Miele E; Miele L; Mukherjee AB Life Sci; 1991; 48(5):453-64. PubMed ID: 1992287 [TBL] [Abstract][Full Text] [Related]
5. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a synthetic nonapeptide from uteroglobin. Marastoni M; Salvadori S; Balboni G; Scaranari V; Santagada V; Romualdi P; Ferri S; Tomatis R Arzneimittelforschung; 1991 Mar; 41(3):240-3. PubMed ID: 1867659 [TBL] [Abstract][Full Text] [Related]
6. Lys 43 and Asp 46 in alpha-helix 3 of uteroglobin are essential for its phospholipase A2 inhibitory activity. Chowdhury B; Mantile-Selvaggi G; Miele L; Cordella-Miele E; Zhang Z; Mukherjee AB Biochem Biophys Res Commun; 2002 Jul; 295(4):877-83. PubMed ID: 12127976 [TBL] [Abstract][Full Text] [Related]
7. The central domain of colicin N possesses the receptor recognition site but not the binding affinity of the whole toxin. Evans LJ; Labeit S; Cooper A; Bond LH; Lakey JH Biochemistry; 1996 Dec; 35(48):15143-8. PubMed ID: 8952461 [TBL] [Abstract][Full Text] [Related]
8. High-resolution crystal structure of a truncated ColE7 translocation domain: implications for colicin transport across membranes. Cheng YS; Shi Z; Doudeva LG; Yang WZ; Chak KF; Yuan HS J Mol Biol; 2006 Feb; 356(1):22-31. PubMed ID: 16360169 [TBL] [Abstract][Full Text] [Related]
9. Topology of the amphipathic helices of the colicin A pore-forming domain in E. coli lipid membranes studied by pulse EPR. Böhme S; Padmavathi PV; Holterhues J; Ouchni F; Klare JP; Steinhoff HJ Phys Chem Chem Phys; 2009 Aug; 11(31):6770-7. PubMed ID: 19639151 [TBL] [Abstract][Full Text] [Related]
10. Uteroglobin inhibits phospholipase A2 activity. Levin SW; Butler JD; Schumacher UK; Wightman PD; Mukherjee AB Life Sci; 1986 May; 38(20):1813-9. PubMed ID: 3084897 [TBL] [Abstract][Full Text] [Related]
11. Uteroglobin: structure, molecular biology, and new perspectives on its function as a phospholipase A2 inhibitor. Miele L; Cordella-Miele E; Mukherjee AB Endocr Rev; 1987 Nov; 8(4):474-90. PubMed ID: 3319534 [TBL] [Abstract][Full Text] [Related]
12. Detection of a uteroglobin-like phospholipase A2 inhibitory protein in the circulation of rabbits. Kikukawa T; Mukherjee AB Mol Cell Endocrinol; 1989 Apr; 62(2):177-87. PubMed ID: 2744226 [TBL] [Abstract][Full Text] [Related]
13. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase. Moreno JJ Int Immunopharmacol; 2006 Feb; 6(2):300-3. PubMed ID: 16399636 [TBL] [Abstract][Full Text] [Related]
14. Structure of the membrane-pore-forming fragment of colicin A. Parker MW; Pattus F; Tucker AD; Tsernoglou D Nature; 1989 Jan; 337(6202):93-6. PubMed ID: 2909895 [TBL] [Abstract][Full Text] [Related]
15. Orientational distribution of alpha-helices in the colicin B and E1 channel domains: a one and two dimensional 15N solid-state NMR investigation in uniaxially aligned phospholipid bilayers. Lambotte S; Jasperse P; Bechinger B Biochemistry; 1998 Jan; 37(1):16-22. PubMed ID: 9453746 [TBL] [Abstract][Full Text] [Related]
16. NMR assignment and backbone dynamics of the pore-forming domain of colicin A. Ibañez de Opakua A; Diercks T; Viguera AR; Blanco FJ Biomol NMR Assign; 2010 Apr; 4(1):33-6. PubMed ID: 19941091 [TBL] [Abstract][Full Text] [Related]
17. Human Clara cell 10-kDa protein is the counterpart of rabbit uteroglobin. Mantile G; Miele L; Cordella-Miele E; Singh G; Katyal SL; Mukherjee AB J Biol Chem; 1993 Sep; 268(27):20343-51. PubMed ID: 8104186 [TBL] [Abstract][Full Text] [Related]
18. Acidic pH-induced membrane insertion of colicin A into E. coli natural lipids probed by site-directed spin labeling. Pulagam LP; Steinhoff HJ J Mol Biol; 2013 May; 425(10):1782-94. PubMed ID: 23399545 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of colicin Y by intramembrane helix-helix interaction with its immunity protein. Smajs D; Dolezalová M; Macek P; Zídek L FEBS J; 2008 Nov; 275(21):5325-31. PubMed ID: 18803667 [TBL] [Abstract][Full Text] [Related]
20. Effect of lipids with different spontaneous curvature on the channel activity of colicin E1: evidence in favor of a toroidal pore. Sobko AA; Kotova EA; Antonenko YN; Zakharov SD; Cramer WA FEBS Lett; 2004 Oct; 576(1-2):205-10. PubMed ID: 15474038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]